ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Collaboration Is Key to Oral Health in Scleroderma & Sjögren’s Disease

Catherine Kolonko  |  November 7, 2025

“The primary pathology in a dental context for Sjögren’s disease is that lymphocytic destruction of the salivary glands,” explained Dr. Trehan. “Whereas for scleroderma, it’s more that fibrosis of the skin and connective tissue.”

Although oral moisture is reduced in both conditions, for patients with Sjögren’s it’s “very markedly” reduced in the form of dry eyes and dry mouth, she said. For scleroderma, the reduction is because of fibrosis of the glands.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Trehan discussed how she topically manages dry mouth for her patients, suggesting over-the-counter sprays, drops, mouthwashes and sugar-free lozenges. Self-massaging of saliva glands, drinking green tea and swishing a teaspoon of coconut oil in the mouth are other ways to manage dryness. “It’s soothing; it promotes saliva,” she noted. “It’s just coconut oil.” However, the oil can clog the sink, so she advised the audience to tell patients to spit it out into a trash bag instead.

To encourage good oral hygiene, healthcare professionals can recommend tools that are designed for people who struggle with restricted movement. To help control disease pain, patients may benefit from physical therapy, massage and muscle relaxants, Dr. Trehan said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Oral health is rheumatologic health,” concluded Dr. Trehan, echoing Dr. Leask’s message. “Collaboration does improve outcomes for our patients and our patient voice really guides our best practices.”


Catherine Kolonko is a medical writer based in Oregon.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsSjögren’s Disease Tagged with:ACR Convergence 2025oral manifestationsSclerodermaSjogren'sSjögren's Disease

Related Articles
    Research Underscores Need to Assess Oral Health in Patients with Systemic Sclerosis

    Research Underscores Need to Assess Oral Health in Patients with Systemic Sclerosis

    November 16, 2016

    Oral health is not frequently considered within the sphere of a rheumatologist’s practice. However, recent results published by the Canadian Scleroderma Research Group (CSRG) point out the importance of assessing oral health in patients with systemic sclerosis (SSc). Result of 3-Year Grant Between 2008 and 2011, 163 patients with SSc and 231 controls were entered…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

    Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

    November 17, 2015

    Despite a generation of advances in molecular biology, a huge gap exists between the Sjögren’s syndrome (SS) patient’s description of their symptoms and the objective findings. Current issues include: Many SS patients are misclassified as either rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), even within rheumatology clinics. Frequently, the sickest SS patients with extraglandular…

    Sjögren’s Dry Eye Requires Collaboration Among Eye Doctors, Rheumatologists

    August 26, 2025

    Sjögren’s dry eye requires collaboration between rheumatologists and ophthalmologists for optimal patient management and treatment of this quality-of-life issue.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences